Finally, TPP‐LND@Lip synergistically increased DNA damage and sensitized radiotherapy via PD‐L1 downregulation and hypoxia reversion by inhibiting mitochondrial OXPHOS, which then significantly inhibited the growth of lung cancer. Here, CD274 is linked to lung cancer.